Central Florida Pathology Associates PA

Central Florida Pathology Associates PA was paid $11.01M by Medicaid between Jan 2018 and Dec 2024, across 286 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 14% of everything it billed.

33Billing provider infoCENTRAL FLORIDA PATHOLOGY ASSOCIATES PA
ORLANDO, FL 32803

33aNPI1255313664assigned 11/19/2005

33bProvider typeAnatomic Pathology & Clinical Pathology Physician

28Total paid$11.01M

24GClaims4,515,880

24DCodes billed286

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Anatomic Pathology & Clinical Pathology Physician providers in Florida

Rank by total paid#2 of 207

Median peer was paid$39K

This provider vs. median281×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	90,507	$54K
2019	620,087	$1.53M
2020	620,277	$1.57M
2021	973,163	$2.23M
2022	926,477	$2.40M
2023	806,450	$2.29M
2024incomplete	478,919	$940K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
80053	Comprehensive metabolic panel	14%	414,527	242,455	$1.57M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	13%	39,985	36,118	$1.45M
88305	Level IV - Surgical pathology, gross and microscopic examination	11%	29,499	25,767	$1.26M
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	6.5%	24,244	20,009	$721K
88307		4.5%	9,567	8,785	$499K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	4.3%	23,048	21,220	$470K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	4.2%	24,686	21,001	$462K
80048	Basic metabolic panel (calcium, ionized)	3.7%	223,413	106,862	$404K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	3.2%	478,323	281,595	$353K
84484		2.9%	97,837	69,705	$321K
82947		2.3%	238,381	67,456	$254K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	1.8%	41,296	39,796	$203K

274 more codes

87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.4%	37,415	$153K
85027		1.2%	177,218	$134K
82803		1.2%	25,938	$128K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	1.1%	9,640	$117K
88189		1.0%	1,678	$113K
83735		<1%	160,728	$103K
88312		<1%	6,277	$91K
87040		<1%	44,786	$90K
84703		<1%	125,490	$83K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	37,421	$77K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	2,925	$70K
83880		<1%	26,823	$66K
83605		<1%	64,439	$61K
84443	Thyroid stimulating hormone (TSH)	<1%	35,743	$59K
81025		<1%	47,138	$57K
87088		<1%	57,429	$53K
86922		<1%	3,394	$53K
85730		<1%	71,012	$47K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	6,650	$46K
86901		<1%	92,092	$46K
83690		<1%	83,972	$45K
86850		<1%	67,914	$39K
81003		<1%	174,157	$37K
80047		<1%	20,254	$37K
87077		<1%	27,050	$36K
84702		<1%	26,453	$36K
87186		<1%	26,277	$36K
85610		<1%	111,112	$35K
84100		<1%	90,794	$35K
88187		<1%	1,892	$34K
87486		<1%	9,695	$31K
87581		<1%	9,665	$31K
81001		<1%	73,239	$31K
87641		<1%	3,370	$30K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	14,383	$29K
86140		<1%	57,289	$28K
87086	Culture, bacterial; quantitative colony count, urine	<1%	22,722	$27K
87070		<1%	19,638	$27K
86900		<1%	92,058	$26K
85060		<1%	3,097	$26K
82330		<1%	18,906	$21K
85576		<1%	1,596	$20K
82247		<1%	29,686	$20K
89060		<1%	2,993	$19K
87483		<1%	231	$17K
85379		<1%	28,960	$17K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	15,279	$16K
83036	Hemoglobin; glycosylated (A1C)	<1%	22,789	$16K
80061	Lipid panel	<1%	17,655	$15K
82533		<1%	2,396	$15K
83020		<1%	2,791	$15K
85007		<1%	28,494	$14K
84145		<1%	33,471	$14K
82728		<1%	17,371	$14K
88313		<1%	1,135	$14K
80076		<1%	19,184	$13K
86923		<1%	12,129	$13K
88304		<1%	1,305	$12K
80074		<1%	3,049	$12K
87497		<1%	2,239	$12K
80202		<1%	11,932	$11K
82550		<1%	24,535	$11K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	1,183	$11K
80197		<1%	8,541	$11K
82607		<1%	9,324	$11K
83970		<1%	3,300	$10K
82248		<1%	16,641	$9K
84466		<1%	5,426	$9K
87653		<1%	3,233	$9K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	633	$9K
86480		<1%	506	$9K
85384		<1%	13,432	$9K
85014		<1%	39,951	$9K
87205		<1%	21,351	$8K
87529		<1%	738	$8K
87799		<1%	1,039	$8K
84439		<1%	12,911	$8K
86880		<1%	11,291	$7K
87210		<1%	28,975	$7K
82746		<1%	6,450	$6K
85652		<1%	20,141	$6K
83615		<1%	18,401	$6K
86255		<1%	1,334	$6K
87081		<1%	11,470	$5K
82140		<1%	5,533	$5K
82784		<1%	3,419	$5K
80050	General health panel	<1%	324	$5K
82570		<1%	14,147	$5K
83540		<1%	11,613	$5K
84295		<1%	13,260	$5K
85045		<1%	12,905	$5K
84132		<1%	16,766	$5K
87075		<1%	5,979	$4K
88342		<1%	536	$4K
87340		<1%	5,975	$4K
83550		<1%	9,192	$4K
87430		<1%	2,675	$4K
87149		<1%	1,133	$4K
85018		<1%	28,039	$4K
83516		<1%	724	$4K
84156		<1%	13,673	$4K
87015		<1%	6,784	$4K
84478		<1%	8,388	$4K
86769		<1%	461	$4K
84030		<1%	9,456	$3K
86334		<1%	1,529	$3K
86762		<1%	2,929	$3K
87536		<1%	192	$3K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	146	$3K
88341		<1%	92	$3K
84112		<1%	704	$3K
86665		<1%	1,140	$3K
87640		<1%	2,216	$3K
87116		<1%	3,234	$3K
82731		<1%	248	$3K
82977		<1%	4,349	$3K
85347		<1%	3,142	$3K
84550		<1%	11,348	$3K
82962		<1%	8,355	$3K
87506		<1%	1,691	$3K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	3,683	$3K
87449		<1%	2,209	$3K
87206		<1%	3,076	$2K
86803		<1%	1,793	$2K
87181		<1%	1,457	$2K
86920		<1%	455	$2K
87102		<1%	3,120	$2K
82010		<1%	6,064	$2K
86592		<1%	7,748	$2K
86832		<1%	409	$2K
82565		<1%	9,503	$2K
87154		<1%	234	$2K
86038		<1%	2,062	$2K
86870		<1%	1,308	$2K
85220		<1%	1,209	$2K
88112		<1%	149	$2K
87420		<1%	2,200	$2K
86706		<1%	2,433	$2K
84481		<1%	1,259	$2K
82810		<1%	1,167	$2K
80069		<1%	2,314	$2K
85525		<1%	986	$2K
85520		<1%	3,399	$2K
87899		<1%	1,828	$2K
85055		<1%	3,914	$1K
80164		<1%	909	$1K
81015		<1%	9,113	$1K
86644		<1%	1,019	$1K
82945		<1%	3,059	$1K
82024		<1%	203	$1K
87496		<1%	187	$1K
84403		<1%	239	$1K
86645		<1%	896	$1K
86808		<1%	201	$1K
86308		<1%	1,599	$1K
87505		<1%	523	$1K
80177		<1%	1,222	$1K
84157		<1%	3,380	$1K
84134		<1%	788	$988.60
82274		<1%	3,542	$984.38
87400		<1%	340	$954.20
83001		<1%	407	$952.21
82105		<1%	564	$935.66
85049		<1%	3,466	$892.90
83003		<1%	114	$889.80
86003		<1%	40	$883.82
89050		<1%	2,320	$845.74
87324		<1%	1,478	$830.99
83010		<1%	1,297	$820.68
80143		<1%	1,434	$819.51
84520		<1%	4,869	$807.26
84681		<1%	410	$781.98
80179		<1%	2,839	$765.53
86664		<1%	293	$748.96
82150		<1%	1,749	$721.78
87071		<1%	1,145	$695.72
83002		<1%	367	$668.67
86403		<1%	705	$653.92
86376		<1%	445	$630.45
86945		<1%	1,085	$630.02
83525		<1%	404	$629.83
86663		<1%	288	$625.43
84300		<1%	2,187	$620.54
88720		<1%	3,791	$618.42
82435		<1%	1,844	$607.38
82378		<1%	419	$595.74
85660		<1%	1,037	$587.06
87522	Neg quan hep c or qual rna	<1%	123	$582.25
84075		<1%	1,216	$576.91
85097		<1%	44	$567.47
83930		<1%	1,166	$553.85
88108		<1%	45	$533.14
87147		<1%	1,479	$529.30
86704		<1%	760	$526.72
80184		<1%	558	$503.34
87807		<1%	200	$487.55
83630		<1%	113	$483.65
83935		<1%	955	$443.78
86800		<1%	231	$442.25
88311		<1%	192	$441.73
82670		<1%	67	$393.36
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	133	$388.12
87631		<1%	120	$324.59
84436		<1%	820	$323.45
86039		<1%	225	$318.17
84480		<1%	362	$299.73
86905		<1%	1,222	$271.26
87184		<1%	517	$255.28
80185		<1%	425	$254.23
85390		<1%	76	$245.03
82785		<1%	173	$237.10
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	1,051	$225.00
86709		<1%	195	$217.57
86160		<1%	145	$211.31
G0452	Molecular pathology procedure; physician interpretation and report	<1%	203	$175.14
86235		<1%	25	$169.65
84450		<1%	701	$154.50
82553		<1%	256	$137.86
84460		<1%	675	$132.28
87046		<1%	151	$131.37
87106		<1%	84	$130.55
86833		<1%	406	$125.43
82077		<1%	6,262	$115.08
85461		<1%	314	$111.73
89051		<1%	475	$111.44
86738		<1%	26	$110.27
86705		<1%	189	$109.87
86225		<1%	91	$109.85
82103		<1%	118	$106.78
84479		<1%	220	$105.90
84133		<1%	572	$105.81
83051		<1%	167	$97.30
86787		<1%	98	$92.81
84146		<1%	68	$90.10
86364		<1%	56	$85.68
82436		<1%	554	$77.88
87045		<1%	149	$77.60
86256		<1%	33	$77.56
82465		<1%	235	$71.41
82657		<1%	14	$63.05
84153		<1%	42	$59.16
82043		<1%	342	$56.18
85362		<1%	230	$52.70
86902		<1%	60	$51.30
88302		<1%	12	$43.34
84165		<1%	158	$40.86
82390		<1%	79	$36.78
80195		<1%	37	$34.72
86141		<1%	65	$33.64
86695		<1%	38	$32.86
87305		<1%	25	$31.84
86430		<1%	77	$30.62
82040		<1%	250	$30.28
85130		<1%	45	$29.86
87185		<1%	186	$26.44
82610		<1%	15	$17.05
87103		<1%	17	$15.26
86985		<1%	1,097	$14.34
85396		<1%	37	$12.50
85008		<1%	38	$10.78
85460		<1%	13	$10.40
87073		<1%	30	$9.81
82310		<1%	37	$7.22
86063		<1%	13	$7.20
82747		<1%	13	$6.10
82575		<1%	12	$5.19
82627		<1%	12	$4.21
80170		<1%	15	$2.67
86593		<1%	13	$0.73
82042		<1%	14	$0.72
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	0%	522	$0.00
87493		0%	169	$0.00
87150		0%	427	$0.00
82397		0%	22	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRANDELL, ROBERT (PRESIDENT)